 Study participants who gave consent and were assessed as eligible in the eligibility assessment will be stratified by the factors of fasting triacylglycerol TG; 300 mgdL or 300 mgdL and age 65 years or 65 years at the start of the screening period and allocated to either the group treated with omega-3-acid ethyl esters or the group not treated with omega-3-acid ethyl esters 1:1 ratio. 